tiprankstipranks
Trending News
More News >
Kalaris Therapeutics (KLRS)
NASDAQ:KLRS
US Market
Advertisement

Kalaris Therapeutics (KLRS) Technical Analysis

Compare
352 Followers

Technical Sentiment

Overall Consensus
Buy
13Bullish
4Neutral
5Bearish
Technical Analysis Consensus
Neutral
3Bullish
4Neutral
3Bearish
Moving Average Consensus
Strong Buy
10Bullish
0Neutral
2Bearish
Kalaris Therapeutics’s (KLRS) Moving Averages Convergence Divergence (MACD) indicator is 0.48, suggesting Kalaris Therapeutics is a Sell.
Kalaris Therapeutics’s (KLRS) 20-Day exponential moving average is 3.37, while Kalaris Therapeutics’s (KLRS) share price is $4.62, making it a Buy.
Kalaris Therapeutics’s (KLRS) 50-Day exponential moving average is 3.16, while Kalaris Therapeutics’s (KLRS) share price is $4.62, making it a Buy.

Kalaris Therapeutics (KLRS) Pivot Points

Sep 08, 2025, 12:35 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
3.36
3.75
4.21
4.60
5.06
5.45
5.91
Fibonacci
3.75
4.08
4.28
4.60
4.93
5.13
5.45
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Kalaris Therapeutics (KLRS) Moving Averages

Sep 08, 2025, 12:35 PM
Period
Simple
Exponential
MA5
4.39Buy
4.31Buy
MA10
3.62Buy
3.84Buy
MA20
3.05Buy
3.37Buy
MA50
2.78Buy
3.16Buy
MA100
3.45Buy
4.19Buy
MA200
6.77Sell
7.57Sell
Kalaris Therapeutics’s (KLRS) 10-Day exponential moving average is 3.84, while Kalaris Therapeutics’s (KLRS) share price is $4.62, making it a Buy.
Kalaris Therapeutics’s (KLRS) 100-Day exponential moving average is 4.19, while Kalaris Therapeutics’s (KLRS) share price is $4.62, making it a Buy.
Kalaris Therapeutics’s (KLRS) stock price is $4.62 and Kalaris Therapeutics’s (KLRS) 50-day simple moving average is 2.78, creating a Buy signal.
Kalaris Therapeutics’s (KLRS) stock price is $4.62 and Kalaris Therapeutics’s (KLRS) 100-day simple moving average is 3.45, creating a Buy signal.
Kalaris Therapeutics’s (KLRS) stock price is $4.62 and Kalaris Therapeutics’s (KLRS) 200-day simple moving average is 6.77, creating a Sell signal.

Kalaris Therapeutics (KLRS) Technical Indicators

Sep 08, 2025, 12:35 PM
Name
Value
Implied Action
RSI (14)
82.24
Sell
STOCH (9,6)
45.45
Neutral
STOCHRSI (14)
47.02
Neutral
MACD (12,26)
0.48
Sell
ADX (14)
36.88
Neutral
Williams %R
-53.88
Buy
CCI (14)
136.45
Sell
ATR (14)
0.54
-
Ultimate Oscillator
44.34
Neutral
ROC
87.80
Buy
Kalaris Therapeutics’s (KLRS) Relative Strength Index (RSI) is 82.24, creating a Sell signal.
Kalaris Therapeutics’s (KLRS) Trend Strength Indicator (ADX) is 36.88, creating a Neutral signal.
Kalaris Therapeutics’s (KLRS) Commodity Channel Index (CCI) is 136.45, creating a Sell signal.
Kalaris Therapeutics’s (KLRS) Price Rate of Change (ROC) is 87.80, creating a Buy signal.

FAQ

Is KLRS a Buy, Hold, or Sell?
Based on KLRS’s technical indicators, KLRS is a Buy.
    What is KLRS’s RSI (14)?
    KLRS’s RSI (14) is 82.24, which suggests KLRS is a Sell.
      What is KLRS’s MACD?
      KLRS’s MACD is 0.48, which suggests KLRS is a Sell.
        What is KLRS’s 5-day moving average?
        KLRS’s 5-day moving average is 4.39, which suggests KLRS is a Buy.
          What is KLRS’s 20-day moving average?
          KLRS 20-day moving average is 3.05, which suggests KLRS is a Buy.
            What is KLRS’s 50-day moving average?
            KLRS’s 50-day moving average is 2.78, which suggests KLRS is a Buy.
              What is KLRS’s 200-day moving average?
              KLRS’s 200-day moving average is 6.77, which suggests KLRS is a Sell.
                What is KLRS’s Williams % R (14)?
                KLRS’s Williams % R (14) is -53.88, which suggests KLRS is a Buy.
                  What is KLRS’s CCI (14)?
                  KLRS’s CCI (14) is 136.45, which suggests KLRS is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis